Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle Interventions

Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle Interventions

Nonalcoholic fatty liver disease (NAFLD) is considered a hepatic manifestation of metabolic syndrome, characterized from pathological changes in lipid and carbohydrate metabolism. Its main characteristics are excessive lipid accumulation and oxidative stress, which create a lipotoxic environment in...

Full description

Bibliographic Details
Main Authors:	Maria Notarnicola, Alberto Ruben Osella, Maria Gabriella Caruso, Pasqua Letizia Pesole, Antonio Lippolis, Valeria Tutino, Caterina Bonfiglio, Valentina De Nunzio, Maria Principia Scavo, Antonella Mirizzi, Isabella Franco, Tamara Lippolis, Rosalba D’Alessandro, Maria Grazia Refolo, Caterina Messa
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Series:	International Journal of Molecular Sciences
Subjects:	NAFLD fatty acids exosomes cytokeratins lipid metabolism Mediterranean diet
Online Access:	https://www.mdpi.com/1422-0067/22/8/3899

Similar Items

Exosomal FZD-7 Expression Is Modulated by Different Lifestyle Interventions in Patients with NAFLD
by: Maria Principia Scavo, et al.
Published: (2022-03-01)

A Low Glycemic Index Mediterranean Diet Combined with Aerobic Physical Activity Rearranges the Gut Microbiota Signature in NAFLD Patients
by: Francesco Maria Calabrese, et al.
Published: (2022-04-01)

Ramucirumab and GSK1838705A Enhance the Inhibitory Effects of Low Concentration Sorafenib and Regorafenib Combination on HCC Cell Growth and Motility
by: Rosalba D’Alessandro, et al.
Published: (2019-06-01)

Premenopausal Syndrome and NAFLD: A New Approach Based on Gender Medicine
by: Livianna Carrieri, et al.
Published: (2022-05-01)

Cytokeratin 18 as a non invasive marker in diagnosis of NASH and its usefulness in correlation with disease severity in Egyptian patients
by: Mohsen M. Maher, et al.
Published: (2015-01-01)

The Effect of Three Mediterranean Diets on Remnant Cholesterol and Non-Alcoholic Fatty Liver Disease: A Secondary Analysis
by: Angelo Campanella, et al.
Published: (2020-06-01)

Synergic effect of Eicosapentaenoic acid and Lovastatin on gene expression of HMGCoA reductase and LDL receptor in cultured HepG2 cells
by: Miccolis Angelica, et al.
Published: (2010-11-01)

Polyunsaturated fatty acids reduce Fatty Acid Synthase and Hydroxy-Methyl-Glutaryl CoA-Reductase gene expression and promote apoptosis in HepG2 cell line
by: Miccolis Angelica, et al.
Published: (2011-01-01)

Plasma-Derived Exosomes from NAFLD Patients Modulate the Cannabinoid Receptors’ Expression in Cultured HepaRG Cells
by: Valentina De Nunzio, et al.
Published: (2023-01-01)

Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease
by: Young Seok Kim, et al.
Published: (2013-06-01)

Increased serum levels of lipogenic enzymes in patients with severe liver steatosis
by: Notarnicola Maria, et al.
Published: (2012-10-01)

The oleic/palmitic acid imbalance in exosomes isolated from NAFLD patients induces necroptosis of liver cells via the elongase-6/RIP-1 pathway
by: Maria Principia Scavo, et al.
Published: (2023-09-01)

Immunohistochemical analysis of cytokeratin 7 and 20 expression in colorectal carcinoma and its correlation with histopathological grading of tumour
by: Santanu Nandy, et al.
Published: (2023-07-01)

Intestinal Sinonasal Adenocarcinoma with Distinct Immunophenotype
by: Monika Sharma, et al.
Published: (2017-12-01)

Inflammatory Mechanisms of HCC Development
by: Maria Grazia Refolo, et al.
Published: (2020-03-01)

Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
by: Shun Ishido, et al.
Published: (2023-06-01)

The Relationship between Cytokeratins 7 and 20 Expression, and Prognostic Factors in Colon Adenocarcinoma: An Immunohistochemical Study
by: Mohammad Hossein Gheini, et al.
Published: (2017-04-01)

Synergistic Effect of Diet and Physical Activity on a NAFLD Cohort: Metabolomics Profile and Clinical Variable Evaluation
by: Francesco Maria Calabrese, et al.
Published: (2023-05-01)

Interaction between sarcopenia and nonalcoholic fatty liver disease
by: Sae Kyung Joo, et al.
Published: (2023-02-01)

Diet and Exercise Exert a Differential Effect on Glucose Metabolism Markers According to the Degree of NAFLD Severity
by: Antonella Bianco, et al.
Published: (2023-05-01)

Citoqueratinas 14 y 19 en quistes y tumores de origen odontogénico: Una revisión
by: Sabrina Nieves, et al.

Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease
by: Ioanna Aggeletopoulou, et al.
Published: (2023-08-01)

Antibody against apolipoprotein-A1, non-alcoholic fatty liver disease and cardiovascular risk: a translational study
by: Sabrina Pagano, et al.
Published: (2023-10-01)

Caspase-Cleaved Keratin 18 Measurements Identified Ongoing Liver Injury after Bariatric Surgery
by: Felix Hempel, et al.
Published: (2021-03-01)

Keratinocytes differentiation and wound healing in rats with streptozotocin – induced diabetes and severe hyperglycemia
by: Evgeniy V. Ivanov, et al.
Published: (2020-04-01)

Hemangiopericytoma: A Rare Mass Arising in the Kidney
by: Gregory Pathrose, et al.
Published: (2018-03-01)

Pan cytokeratin expression by meningiomas of the brain
by: S. I. Tertishniy, et al.
Published: (2015-04-01)

The Effect of Low Glycemic Index Mediterranean Diet and Combined Exercise Program on Metabolic-Associated Fatty Liver Disease: A Joint Modeling Approach
by: Ritanna Curci, et al.
Published: (2022-07-01)

Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
by: Sebastião M.B. Duarte, et al.
Published: (2019-05-01)

Changes in Cytokeratin 18 during Neoadjuvant Chemotherapy of Breast Cancer: A Prospective Study
by: Danial Fazilat-Panah, et al.
Published: (2020-04-01)

Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease
by: Kevan Josloff, et al.
Published: (2022-11-01)

Nutraceuticals: Focus on Anti-Inflammatory, Anti-Cancer, Antioxidant Properties in Gastrointestinal Tract
by: Giusy Rita Caponio, et al.
Published: (2022-06-01)

Pharmacological potential of ginseng and ginsenosides in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Young-Su Yi
Published: (2024-03-01)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019-09-01)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019-09-01)

Lessons on Drug Development: A Literature Review of Challenges Faced in Nonalcoholic Fatty Liver Disease (NAFLD) Clinical Trials
by: Joel Yeh Siang Chen, et al.
Published: (2022-12-01)

Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for the Diagnosis of Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
by: Sebastian Zenovia, et al.
Published: (2021-04-01)

What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
by: Giovanni Tarantino, et al.
Published: (2024-02-01)

Non-invasive predictors of prognosis of Asian patients with histopathologically-confirmed lean nonalcoholic fatty liver disease
by: Soichi Iritani, et al.
Published: (2020-11-01)

Letter regarding “Risk factors in nonalcoholic fatty liver disease”
by: Abhijit Pratap, et al.
Published: (2023-10-01)